Chantal Castagné

Systematic screening at diagnosis of −5/del(5)(q31), −7, or chromosome 8 aneuploidy by interphase fluorescence in situ hybridization in 110 acute myelocytic leukemia and high-risk myelodysplastic syndrome patients: concordances and discrepancies with conventional cytogenetics

Valérie Beyer, Chantal Castagné, Dominique Mühlematter et al. · Cancer Genetics and Cytogenetics · 2004 · 39 citations

Hematological Malignancy, Cytogenetics, Interphase Fluorescence +13

Tetrasomy 8 in a patient with acute nonlymphocytic leukemia: A metaphase and interphase study with fluorescence in situ hybridization

Dominique Mühlematter, Chantal Castagné, O. Bruzzese et al. · Cancer Genetics and Cytogenetics · 1996 · 17 citations

Hematological Malignancy, Medicine, Mixed-phenotype Acute Leukemia +10

Partial trisomy 20q in a newborn with dextrocardia.

Marie-Claude Addor, Chantal Castagné, J.L. Micheli et al. · PubMed · 2002 · 10 citations

Pediatric Heart Disease, Genetics, Congenital Heart Anomaly +17

Determination of cutoff values to detect small aneuploid clones by interphase fluorescence in situ hybridization: the Poisson model is a more appropriate approach. Should single-cell trisomy 8 be considered a clonal defect?

Chantal Castagné, Dominique Mühlematter, Valérie Beyer et al. · Cancer Genetics and Cytogenetics · 2003 · 10 citations

Cutoff Values, Developmental Biology, Hybridisation +11